Global Peripheral Embolization Device Market Size and Share, Product Type (Platinum Coils, Embolization Guidewires, Microcatheters, Occlusion Systems, and Occlusion Balloons), By Application (Hospitals, Ambulatory surgical centers, and Specialty clinics), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Peripheral Embolization Device Market Insights Forecasts to 2035

• The Global Peripheral Embolization Device Market Size Was Estimated at USD 690.6 Million in 2025
• The Market Size is Expected to Grow at a CAGR of around 7.05% from 2025 to 2035
• The Worldwide Peripheral Embolization Device Market Size is Expected to Reach USD 1365.2 Million by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

According To A Research Report Published By Spherical Insights And Consulting, The Global Peripheral Embolization Device Market Size Was Worth Around USD 690.6 Million In 2025 And Is Predicted To Grow To Around USD 1365.2 Million By 2035 With A Compound Annual Growth Rate (CAGR) Of 7.05% From 2025 To 2035. The market for peripheral embolization devices presents significant opportunities due to the increasing demand for minimally invasive treatments, expanding applications in the management of vascular disease and oncology, technological advancements in embolic materials, rising global adoption of image-guided interventional procedures, and growing healthcare investments.

Market Overview

The global industry that develops, produces, distributes, and markets medical devices intended to purposefully obstruct or lessen blood flow in peripheral blood vessels for therapeutic purposes is known as the peripheral embolization device market. To treat problems including peripheral vascular malformations, aneurysms, tumors, gastrointestinal bleeding, trauma-related hemorrhage, and other vascular abnormalities, these devices are frequently employed in minimally invasive interventional treatments. Embolic coils, vascular plugs, liquid embolics, microspheres, and particle agents are examples of peripheral embolization devices that allow targeted artery occlusion while reducing tissue damage.

In June 2025, Penumbra, Inc. launched the Ruby® XL System following FDA clearance. Designed as the longest, largest, and softest embolization coil available, the system enhances embolization efficiency, supports large-vessel and high-flow procedures, reduces radiation exposure, and helps optimize clinical outcomes. The rising incidence of vascular disorders, aneurysms, tumors, and hemorrhagic situations that call for efficient blood vessel occlusion treatments is the main factor propelling the growth of the peripheral embolization device market.  The need for embolization operations is also rising as a result of the aging population's increased frequency of chronic vascular disorders.  

Report Coverage

This research report categorizes the Peripheral Embolization Device market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Peripheral Embolization Device market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Peripheral Embolization Device market.   

Driving Factors

The rising incidence of vascular disorders, aneurysms, tumors, and hemorrhagic situations that call for efficient blood vessel occlusion treatments is the main factor propelling the growth of the peripheral embolization device market. Because embolization techniques provide lower surgical risks, shorter hospital stays, quicker recovery periods, and better patient outcomes than conventional surgical therapies, the growing use of less invasive procedures is a significant reason. Treatment efficacy and procedural safety have been improved by developments in embolization technology, such as the creation of extremely accurate embolic coils, vascular plugs, liquid embolics, and microspheres.

Restraining Factors  

The high cost of embolization procedures and devices, strict regulatory approval requirements, a shortage of qualified interventional specialists, possible procedural complications, and limited access to cutting-edge healthcare facilities in developing regions are some of the challenges facing the peripheral embolization device market.

Market Segmentation    

The Peripheral Embolization Device market share is classified into Product Type and application.    

• The platinum coils segment dominated the market in 2025, approximately 35.2%, and is projected to grow at a substantial CAGR during the forecast period.    

Based on the Product Type, the Peripheral Embolization Device market is divided into platinum coils, embolization guidewires, microcatheters, occlusion systems, and occlusion balloons. Among these, the platinum coils segment dominated the market in 2025, approximately 35.2%, and is projected to grow at a substantial CAGR during the forecast period. The special qualities of platinum, such as its high radiopacity, flexibility, and biocompatibility, are what motivate the use of platinum coils, which enable medical professionals to precisely position and permanently occlude aberrant vessels. Platinum coils are widely used in embolization operations because of their exceptional flexibility, radiopacity, biocompatibility, and precise deployment capabilities.  

• The hospitals segment accounted for the highest market revenue in 2025, approximately 58.7%, and is anticipated to grow at a significant CAGR during the forecast period.           

Based on the application, the Peripheral Embolization Device market is divided into hospitals, ambulatory surgical centers, and specialty clinics. Among these, the hospitals segment accounted for the highest market revenue in 2025, approximately 58.7%, and is anticipated to grow at a significant CAGR during the forecast period. The availability of sophisticated interventional radiology equipment, qualified medical personnel, and the extensive infrastructure needed to carry out intricate embolization procedures are what propel North America.  When it comes to vascular problems, aneurysms, tumors, and trauma-related bleeding situations that need embolization therapy, hospitals are the main treatment facilities.

Regional Segment Analysis of the Peripheral Embolization Device Market   

• North America (U.S., Canada, Mexico)   
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the Peripheral Embolization Device market over the predicted timeframe.       

North America is anticipated to hold the largest share of the Peripheral Embolization Device market over the predicted timeframe. North America is driven by substantial acceptance of minimally invasive vascular procedures, attractive reimbursement policies, high procedural volumes, and sophisticated healthcare infrastructure. Recent advancements include Medtronic's July 2025 start of the OnyxTM Liquid Embolic IDE Clinical Study for the treatment of peripheral arterial bleeding and Penumbra's June 2025 introduction of the Ruby® XL System, an improved embolization coil platform for large-vessel embolization treatments. These developments strengthen the area's position as a leader in the use of embolization technology and clinical progress.

Asia Pacific is expected to grow at a rapid CAGR in the Peripheral Embolization Device market during the forecast period. The growing availability to interventional radiology services, rising healthcare costs, the prevalence of vascular diseases, and developing healthcare infrastructure. The wider commercialization of Instylla's TemboTM Embolic System after FDA approval and rising regional investments in cutting-edge embolization technology are examples of recent market trends. In order to facilitate the quicker adoption of next-generation peripheral embolization devices throughout the region, manufacturers are also extending distribution networks and physician training programs in China, India, Japan, and Southeast Asia.

Competitive Analysis:  

The report offers the appropriate analysis of the key organizations/companies involved within the Peripheral Embolization Device market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.   

List of Key Companies

• Abbott Laboratories
• Boston Scientific Corporation
• Cook Medical
• Johnson & Johnson (DePuy Synthes)
• Medtronic
• Merit Medical Systems, Inc.
• Penumbra, Inc.
• Sirtex Medical Limited
• Stryker Corporation
• Terumo Corporation
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In June 2025, Embolization launched its Nitinol Enhanced Device (NED) following U.S. FDA 510(k) clearance. The vascular embolization device is designed for arterial and venous embolization procedures in peripheral vasculature, expanding treatment options and supporting advanced minimally invasive vascular interventions.
• In March 2025, Inari Medical, now part of Stryker, launched the Artix Thrombectomy System, a combined aspiration and mechanical thrombectomy solution designed for peripheral arterial procedures, offering enhanced procedural control, versatility, and improved clot-removal performance for vascular interventions.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Peripheral Embolization Device market based on the below-mentioned segments: 

Global Peripheral Embolization Device Market, By Product Type

• Platinum Coils
• Embolization Guidewires
• Microcatheters
• Occlusion Systems
• Occlusion Balloons

Global Peripheral Embolization Device Market, By Application

• Hospitals
• Ambulatory surgical centers
• Specialty clinics

Global Peripheral Embolization Device Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa